Test-to-Treat for Pharmacy is Here.
IS YOUR PHARMACY READY?
Operationalize Test-to-Treat in your pharmacy.
As you may have heard, the FDA has granted limited prescriptive authority to pharmacists for COVID-19 antiviral, Paxlovid. Test-to-Treat is here.
What does this really mean for pharmacy? And what’s next to operationalize Test-to-Treat within the pharmacy environment?
Hear David Pope, PharmD, CDE, Chief of Pharmacy and Shelley Hansell, EVP Client Relations & RCM Product Management in a townhall-style webinar, to discuss all of the crucial nuances involved in pharmacy’s Test-to- Treat model – including medical billing strategies.
David Pope, PharmD, CDE, Chief of Pharmacy
Shelley Hansell, EVP Client Relations & RCM Product Management
Watch the Test-to-Treat Townhall!
Tune in to hear David Pope, PharmD, CDE, EVP Innovation & Industry Relations and Shelley Hansell, EVP, Client Relations & RCM Product Management discuss what this means for pharmacy today, and the crucial next steps to operationalize test and treat in the pharmacy.
